Adolescent cannabinoid exposure delays development of prefrontal cortex perineuronal nets and inhibitory interneurons

Eliza Jacobs-Brichford1, Rachel M Donka1, Amy W Lasek2

  • 1Department of Psychology, University of Illinois Chicago, Chicago, IL 60607, United States.

Neuroscience
|March 25, 2026
PubMed

Insights

Adolescent cannabinoid exposure, particularly WIN 55, 212-2, disrupts perineuronal net (PNN) development in the prefrontal cortex (PFC). This can impair inhibitory signaling and executive function, with lasting effects observed in male rats.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • Inhibitory signaling in the prefrontal cortex (PFC) matures during adolescence, influenced by experience.
  • Parvalbumin-positive (PV+) interneurons and their surrounding perineuronal nets (PNNs) are crucial for this maturation.
  • The endocannabinoid system modulates neural activity and excitatory-inhibitory balance.

Purpose of the Study:

  • To investigate the impact of cannabinoid receptor stimulation on PFC inhibitory signaling during adolescent development.
  • To determine sex differences in the effects of cannabinoid exposure on PNN and PV+ cell maturation.

Main Methods:

  • Male and female rats were treated with the synthetic cannabinoid WIN 55, 212-2 (WIN) during adolescence (postnatal days 35-45).
  • Changes in PNNs and PV+ cells were assessed at various developmental stages (juvenile, adolescent, adult).
  • Neural activity in the PFC of adult rats was recorded following adolescent WIN treatment.

Main Results:

  • WIN treatment reduced PNNs and delayed PV+ cell emergence in the PFC.
  • These effects were observed earlier in females but persisted into adulthood in males.
  • Adolescent WIN exposure led to disinhibition of PFC neural activity in adulthood, more pronounced in males.

Conclusions:

  • Cannabinoid exposure during adolescence can disrupt PNN development and alter PFC inhibitory signaling.
  • These disruptions may have long-lasting consequences on executive control of behavior.
  • Sex differences exist in the timing and persistence of these cannabinoid-induced neurodevelopmental effects.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K